pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 501–600 of 1,003
Klangby, U., Okan, İ., Magnússon, K. P., Wendland, M., Lind, P., & Wiman, K. G. (1998) · Blood · doi:10.1182/blood.v91.5.1680 · Cited by 106
Paige, A. J. W., Taylor, K. J., Stewart, A., SGOUROS, J. G., Gabra, H., Sellar, G., Smyth, J. F., Porteous, D. J., & Watson, J. E. V. (2000) · PubMed · Cited by 111
Temperature-Sensitive Mutants of p16CDKN2 Associated with Familial Melanoma
Parry, D., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3844 · Cited by 94
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
Sartor, M., Steingrimsdottir, H., Elamin, F., Gäken, J. A., Warnakulasuriya, S., Partridge, M., Thakker, N., Johnson, N. W., & Tavassoli, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690505 · Cited by 103
Singh, G., Singh, S. K., König, A. O., Reutlinger, K., Nye, M. D., Adhikary, T., Eilers, M., Gress, T. M., Fernández-Zapico, M. E., & Ellenrieder, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100438 · Cited by 99
JNK Regulates Autocrine Expression of TGF-β1
Ventura, J., Kennedy, N. J., Flavell, R. A., & Davis, R. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.007 · Cited by 107
Pin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion
Matsuura, I., Chiang, K.-N., Lai, C., He, D., Wang, G., Ramkumar, R., Uchida, T., Ryo, A., Lu, K.-P., & Liu, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063826 · Cited by 95
Molecular Biology for the Radiation Oncologist: the 5Rs of Radiobiology meet the Hallmarks of Cancer
Harrington, K. J., Jankowska, P., & Hingorani, M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.04.009 · Cited by 115
Worsham, M. J., Pals, G., Schouten, J. P., Miller, F. W., Tiwari, N., van Spaendonk, R. M. L., & Wolman, S. R. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9077-8 · Cited by 90
Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy.
Franch, H. A., Shay, J. W., Alpern, R. J., & Preisig, P. A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.1.245 · Cited by 96
Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Matsushima-Nishiu, M., Unoki, M., Ono, K., Tsunoda, T., Minaguchi, T., Kuramoto, H., Nishida, M., Satoh, T., Tanaka, T., & Nakamura, Y. (2001) · PubMed · Cited by 102
Bedke, N., Sammut, D., Green, B., Kehagia, V., Dennison, P. W., Jenkins, G. R., Tatler, A. L., Howarth, P. H., Holgate, S. T., & Davies, D. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044580 · Cited by 94
Functional Mechanisms for Human Tumor Suppressors
Sun, W., & Yang, J. P. (2010) · Journal of Cancer · doi:10.7150/jca.1.136 · Cited by 115
Sequential Unfolding of Ankyrin Repeats in Tumor Suppressor p16
Tang, K. S., Fersht, A. R., & Itzhaki, L. S. (2003) · Structure · doi:10.1016/s0969-2126(02)00929-2 · Cited by 105
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 96
Ramalingam, A., Hirai, A. M., & Thompson, E. A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.5.9923 · Cited by 96
Arendt, T. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00216-5 · Cited by 97
Venkataramani, R. N., Swaminathan, K., & Marmorstein, R. (1998) · Nature Structural Biology · doi:10.1038/nsb0198-74 · Cited by 89
Cellular Transformation by the HTLV-I Tax Protein, a Jack-of-All-Trades
Gatza, M. L., Watt, J. C., & Marriott, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206549 · Cited by 103
Estanyol, J. M., Jaumot, M., Casanovas, O., Rodriguez-Vilarrupla, A., Agell, N., & Bachs, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33161 · Cited by 88
Kinase Inhibitors in Cancer Therapy: A Look Ahead
Sedlacek, H. H. (2000) · Drugs · doi:10.2165/00003495-200059030-00004 · Cited by 98
Negative regulation of cell growth by TGFβ
Polyák, K. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00009-5 · Cited by 107
Dobashi, Y., Kudoh, T., Matsumine, A., Toyoshima, K., & Akiyama, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23031 · Cited by 92
CDKN2A (p16INK4A) somatic and germline mutations
Smith-Sørensen, B., & Hovig, E. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)7:4<294::aid-humu2>3.0.co;2-9 · Cited by 87
APOPTOSIS OF CRYPT EPITHELIAL CELLS IN ULCERATIVE COLITIS
IWAMOTO, M., KOJI, T., MAKIYAMA, K., KOBAYASHI, N., & NAKANE, P. K. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199610)180:2<152::aid-path649>3.0.co;2-y · Cited by 312
Kelly, B. L., Wolfe, K. G., & Roberts, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2535 · Cited by 103
LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
Kim, J. H., Karnovsky, A., Mahavisno, V., Weymouth, T. E., Pande, M., Dolinoy, D. C., Rozek, L. S., & Sartor, M. A. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-526 · Cited by 104
Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice
Shinagawa, T., Nomura, T., Colmenares, C., Ohira, M., Nakagawara, A., & Ishii, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204987 · Cited by 87
Kranc, K. R., Bamforth, S. D., Bragança, J., Norbury, C., van Lohuizen, M., & Bhattacharya, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7658-7666.2003 · Cited by 86
The role of transforming growth factor Β in glioma progression
Jennings, M. T., & Pietenpol, J. A. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005863419880 · Cited by 99
Pathway-specific tumor suppression
Staheli, J. P., Kim, K.-H., Payne, S. R., Gurley, K. E., Liggitt, D., Longton, G., & Kemp, C. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00054-5 · Cited by 91
Phelps, D. E., Hsiao, K.-M., Li, Y., Hu, N., Franklin, D. S., Westphal, E., Lee, E. Y.-H. P., & Xiong, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2334 · Cited by 86
Paul, T. A., Bies, J., Small, D., & Wolff, L. (2010) · Blood · doi:10.1182/blood-2009-07-233858 · Cited by 91
Molecular Analysis of the 9p21 Locus and p53 Genes in Ewing Family Tumors
López‐Guerrero, J. A., Pellín, A., Noguera, R., Cardá, C., & Llombart‐Bosch, A. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780290 · Cited by 89
“Among these CDKI are p16INK4A (MTS1, CDKN2) (Kamb et al, 1994; Serrano et al, 1993) and p15INK4B (MTS2) (Hannon and Beach, 1994), which form binary complexes exclu- sively with CDK4 and CDK6, inhibiting their function and, by so doing, inhibiting pRb phosphorylation during G1 (Graña and Reddy,…”
BackgroundCell cycle profiles and expressions of p21CIP1 and p27KIP1 during myocyte development
Poolman, R. A., Gilchrist, R., & Brooks, G. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00320-9 · Cited by 93
Role of the RB Tumor Suppressor in Cancer
Yamasaki, L. (2006) · Cancer Treatment and Research · doi:10.1007/0-306-48158-8_9 · Cited by 84
G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.
Kudoh, T., Ishidate, T., Moriyama, M., Toyoshima, K., & Akiyama, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4517 · Cited by 94
Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
Ha, T. U., Segev, D. L., Barbie, D. A., Masiakos, P. T., Tran, T. T., Dombkowski, D., Glander, M., Clarke, T. R., Lorenzo, H. K., Donahoe, P. K., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005701200 · Cited by 98
Urano, T., Yashiroda, H., Muraoka, M., Tanaka, K., Hosoi, T., Inoue, S., Ouchi, Y., Tanaka, K., & Toyoshima, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12197 · Cited by 89
TGF-β Family Signaling Pathways in Cellular Dormancy
Prunier, C., Baker, D. A., ten Dijke, P., & Ritsma, L. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.10.010 · Cited by 94
Coronary Artery Disease–Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis
Samani, N. J., Raitakari, O. T., Sipilä, K., Tobin, M. D., Schunkert, H., Juonala, M., Braund, P. S., Erdmann, J., Viikari, J. S. A., Moilanen, L., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.170332 · Cited by 89
Overexpression of Cyclin‐dependent Kinase‐activating CDC25B Phosphatase in Human Gastric Carcinomas
Kudo, Y., Yasui, W., Ue, T., Yamamoto, S., Yokozaki, H., Nikai, H., & Tahara, E. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00313.x · Cited by 91
Uchida, F., Uzawa, K., Kasamatsu, A., Takatori, H., Sakamoto, Y., Ogawara, K., Shiiba, M., Tanzawa, H., & Bukawa, H. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-321 · Cited by 82
The Endogenous Ratio of Smad2 and Smad3 Influences the Cytostatic Function of Smad3
Kim, S. G., Kim, H., Jong, H.-S., Park, J., Kim, N. K., Hong, S. H., Kim, T.-Y., & Bang, Y. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0054 · Cited by 96
“…factor c-myc and the transcriptional activation of the cyclin-dependent kinase (Cdk) inhibitors p15INK4b and/or p21Cip1 (Pietenpol et al., 1990; Hannon and Beach, 1994; Datto et al., 1995), which results in the inhibition of G1 Cdk activities and the subsequent accumulation of…”
BackgroundShimamoto, T., Ohyashiki, J. H., & Ohyashiki, K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2004.11.014 · Cited by 90
Zoumpourlis, V. C., Solakidi, S., Papathoma, A., & Papaevangeliou, D. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg067 · Cited by 84
Olopade, O. I., Pomykala, H. M., Hagos, F., Sveen, L. W., Espinosa, R., Dreyling, M. H., Gursky, S., Stadler, W. M., Le Beau, M. M., & Bohlander, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6489 · Cited by 82
Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis
Dalla, E., Papanicolaou, M., Park, M. D., Barth, N. D., Hou, R., Segura-Villalobos, D., Salazar, L. E. V., Sun, D., Forrest, A. R. R., Casanova-Acebes, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.016 · Cited by 99
Orleans-Lindsay, J. K., Barber, L. D., Prentice, H. G., & Lowdell, M. W. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01692.x · Cited by 82
Zhou, L., Zhang, X., He, M., Cheng, L., Chen, Y., Hu, F. B., & Wu, T. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.176065 · Cited by 82
Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas
Yoshino, A., Katayama, Y., Ogino, A., Watanabe, T., Yachi, K., Ohta, T., Komine, C., Yokoyama, T., & Fukushima, T. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9316-9 · Cited by 87
Kanellou, P., Zaravinos, A., Zioga, M., Stratigos, A., Baritaki, S., Soufla, G., Zoras, O., & Spandidos, D. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.042 · Cited by 90
Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas
Izumoto, S., Arita, N., Ohnishi, T., Hiraga, S., Taki, T., Tomita, N., Ohue, M., & Hayakawa, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04583-1 · Cited by 81
Perrone, F., Tabano, S. M., Colombo, F., Dagrada, G. P., Birindelli, S., Gronchi, A., Colecchia, M., Pierotti, M. A., & Pilotti, S. (2003) · PubMed · Cited by 88
Genetic and Molecular Markers of Urothelial Premalignancy and Malignancy
Cordon‐Cardo, C., Côté, R. J., & Sauter, G. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169338 · Cited by 83
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
Herrera, R. E., Mäkelä, T. P., & Weinberg, R. A. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1335 · Cited by 81
Peters, G. G. (1994) · Nature · doi:10.1038/371204a0 · Cited by 88
Pouliot, F., & Labrie, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720187 · Cited by 92
“In addition, TGF- and Smad3 response elements identified respectively by Datto et al. (1995a), Pardali et al. (2000) and Moustakas and Kardassis (1998) are located between positions 124 and 60.”
BackgroundInfluentialMukherjee, P., Winter, S. L., & Alexandrow, M. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01152-09 · Cited by 94
Gu, S., & Feng, X. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy092 · Cited by 84
Puig, S., Ruiz, A., Lázaro, C., CASTEL, T., Lynch, M., Palou, J., Vilalta, A., Weissenbach, J., Mascaró, J. M., & Estivill, X. (1995) · Europe PMC (PubMed Central) · Cited by 95
Ferrando, A., Balbín, M., Pendás, A. M., Vizoso, F. J., Velasco, G., & López-Otín, C. (1996) · Human Genetics · doi:10.1007/bf00218840 · Cited by 86
Disorder-function relationships for the cell cycle regulatory proteins p21 and p27
Mitrea, D. M., Yoon, M., Li, O., & Kriwacki, R. W. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0254 · Cited by 87
“The INK4 family members, including p16 (Serrano et al. , 1993 ), p15 (Hannon and Beach , 1994 ), p18 (Guan et al. , 1994 ), and p19 (Hirai et al. , 1995 ), bind Cdk4 and Cdk6 and prevent their complexation with D-type cyclins, causing cell cycle arrest in early G 1 phase.”
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
Guo, P., Zhao, K.-W., Dong, X.-Y., Sun, X., & Dong, J.-T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007096 · Cited by 79
Modulation of radiation damage by cytokines
Neta, R. (2009) · Stem Cells · doi:10.1002/stem.5530150713 · Cited by 84
Transforming Growth Factor-β: Biology and Clinical Relevance
Kim, I. Y., Kim, M. M., & Kim, S. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.1.001 · Cited by 90
“Downstream targets of TGF-β regulated transcription include p15INK4B (Hannon & Beach, 1994) and p21CIP1 (Datto et al., 1995) both of which are important “brakes” in the cell cycle. p21CIP1, a cyclin dependent kinase inhibitor, interacts with CDK2/cyclin A and CDK2/cyclin E complexes, preventing…”
BackgroundFlørenes, V. A., Lü, C., Bhattacharya, N., Rak, J. W., Sheehan, C., Slingerland, J. M., & Kerbel, R. S. (1999) · Oncogene · doi:10.1038/sj.onc.1202382 · Cited by 84
Cheng, T., Shen, H., Rodrigues, N., Stier, S., & Scadden, D. T. (2001) · Blood · doi:10.1182/blood.v98.13.3643 · Cited by 79
Imaizumi, N., Monnier, Y., Hegi, M. E., Mirimanoff, R., & Rüegg, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011084 · Cited by 90
Palanca-Wessels, M. C., Barrett, M. T., Galipeau, P. C., Rohrer, K. L., Reid, B. J., & Rabinovitch, P. S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70480-9 · Cited by 67
Prognostic Value of p27Kip1 and CyclinD1 Expression in Esophageal Cancer
Itami, A., Shimada, Y., Watanabe, G., & Imamura, M. (1999) · Oncology · doi:10.1159/000012067 · Cited by 81
Up-regulation of Transforming Growth Factor (TGF)-β Receptors by TGF-β1 in COLO-357 Cells
Kleeff, J. H., & Korc, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7495 · Cited by 80
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
Bertoni, F., Codegoni, A. M., Furlan, D., Tibiletti, M. G., Capella, C., & Broggini, M. (1999) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199910)26:2<176::aid-gcc11>3.0.co;2-3 · Cited by 121
FOXC1, the new player in the cancer sandbox
Elian, F., Yan, E., & Walter, M. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22742 · Cited by 84
Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer
Shen, L., Qu, X., Ma, Y., Zheng, J., Chu, D., Liu, B., Li, X., Wang, M., Xu, C., Liu, N., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2013.48 · Cited by 77
Cellular context‐dependent “colors” of transforming growth factor‐β signaling
Ikushima, H., & Miyazono, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01441.x · Cited by 90
Guo, P., Dong, X., Zhang, X., Zhao, K., Sun, X., Li, Q., & Dong, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806270200 · Cited by 76
Tong, W., Kiyokawa, H., Soos, T. J., Park, M. S., Soares, V. C., Manova, K., Pollard, J. W., & Koff, A. (1998) · PubMed · Cited by 81
DE BOSSCHER, K., HILL, C. S., & NICOLÁS, F. J. (2004) · Biochemical Journal · doi:10.1042/bj20031886 · Cited by 77
Monkawa, T., Hiromura, K., Wolf, G., & Shankland, S. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013162.29833.45 · Cited by 77
Carrageenan Induces Cell Cycle Arrest in Human Intestinal Epithelial Cells in Vitro3
Bhattacharyya, S., Borthakur, A., Dudeja, P. K., & Tobacman, J. K. (2008) · Journal of Nutrition · doi:10.1093/jn/138.3.469 · Cited by 80
Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL)
Hatta, Y., & Koeffler, H. (2002) · Leukemia · doi:10.1038/sj.leu.2402458 · Cited by 90
Iglesias, M., Frontelo, P., Gamallo, C., & Quintanilla, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203764 · Cited by 85
Cell Cycle Genes in Ovarian Cancer
D’Andrilli, G., Kumar, C., Scambia, G., & Giordano, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0886 · Cited by 76
Chang, H. W., Ling, G. S., Wei, W., & Yuen, A. P. W. (2004) · Cancer · doi:10.1002/cncr.20323 · Cited by 75
Choi, K. S., Eom, Y. W., KANG, Y. Y., Ha, M. J., Rhee, H. H., Yoon, J., & Kim, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31775 · Cited by 79
Moller, H., & Skakkebæk, N. E. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960503)66:3<287::aid-ijc2>3.0.co;2-v · Cited by 192
E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest
Mann, D. J., & Jones, N. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00515-8 · Cited by 95
Teofili, L., Martini, M., Luongo, M., Diverio, D., Capelli, G., Breccia, M., Coco, F. L., Leone, G. G. M., & Larocca, L. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402907 · Cited by 74
Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
Chen, J., Ding, Z., Li, S., Liu, S., Xiao, C., Li, Z., Zhang, B., Chen, X., & Yang, X. (2020) · Theranostics · doi:10.7150/thno.51383 · Cited by 82
Depoortere, F., Pirson, I., Bártek, J., Dumont, J. E., & Roger, P. P. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.1061 · Cited by 78
“In keratinocytes and mammary cells, TGFb induces the cdk4 inhibitor p15INK4B without modifying cdk4 and d-type cyclin expression (Hannon and Beach, 1994).”
BackgroundLubomierski, N., Kersting, M., Bert, T., Muench, K., Wulbrand, U., Schuermann, M., Bartsch, D., & Simon, B. (2001) · PubMed · Cited by 82
Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4
Ding, Q.-M., Ko, T. C., & Evers, B. M. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.5.c1193 · Cited by 82
Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity
Lilischkis, R., Šarčević, B., Kennedy, C. J., Warlters, A., & Sutherland, R. L. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960410)66:2<249::aid-ijc19>3.0.co;2-7 · Cited by 81
Transcriptomic changes during TGF-β-mediated differentiation of airway fibroblasts to myofibroblasts
Walker, E. J., Heydet, D., Veldre, T., & Ghildyal, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-56955-1 · Cited by 72
A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac Death
Newton-Cheh, C., Cook, N. R., VanDenburgh, M., Rimm, E. B., Ridker, P. M., & Albert, C. M. (2009) · Circulation · doi:10.1161/circulationaha.109.879049 · Cited by 74
A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease
Chen, Z., Qian, Q., Ma, G., Wang, J., Zhang, X., Feng, Y., Shen, C., & Yao, Y. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9259-7 · Cited by 73
Iglesias, A. I., Springelkamp, H., van der Linde, H., Severijnen, L.-A. W. F. M., Amin, N., Oostra, B. A., Kockx, C. E. M., van den Hout, M. C. G. N., van IJcken, W. F. J., Albert Hofman, D., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt522 · Cited by 78
Bown, M. J., Braund, P. S., Thompson, J. R., London, N. J. M., Samani, N. J., & Sayers, R. D. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.789727 · Cited by 73
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.